Position in ALKS
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$209
+$33 QoQ
Shares Held
4
-20.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#414
of 421 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Abound Wealth Management holds $8,320 across 10 Drug Manufacturers - Specialty & Generic names. ALKS ranks #7 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
172 | $2,731 | |
| 2 | ZTS |
Zoetis Inc.
|
31 | $2,227 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
74 | $1,821 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
36 | $521 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
6 | $246 | |
| 6 | LQDA |
Liquidia Corp
|
3 | $239 | |
| 7 | ALKS |
Alkermes plc.
This page
|
4 | $209 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
4 | $138 |
All Filings in ALKS
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $209 | 4 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $176 | 5 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $223 | 8 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $240 | 8 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $228 | 8 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $264 | 8 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $287 | 10 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $279 | 10 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $241 | 10 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $541 | 20 | Shares | Sole | 2024-08-08 | |
| No filing history on record for this holder in this stock. | ||||||